Hi All
The Edison report valued the company at about $199m with the Immutep acquisition plus CVAC. I guess the true value boils down to how much investors want to discount that value and what their individual risk appetites are...
If we take the current value of the company at $199m and the number of issued shares at 1.71b, the value is about 11c per share . Could this explain why the share price on the ASX has been hovering around this level?
- Forums
- ASX - By Stock
- pre market.
Hi All The Edison report valued the company at about $199m with...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.035(9.86%) |
Mkt cap ! $464.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.5¢ | 31.5¢ | $2.884M | 8.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 264808 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 205318 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 264808 | 0.315 |
8 | 222575 | 0.310 |
10 | 133368 | 0.305 |
20 | 614318 | 0.300 |
3 | 78900 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 205318 | 5 |
0.330 | 274299 | 2 |
0.335 | 40625 | 2 |
0.340 | 79941 | 4 |
0.345 | 92237 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online